|
With ADP coming in half of what was expected and Q1 GDP -0.3%, we can understand the downward pressure in the pre-market.
|
|
|
Investors need to pay close attention to LMNR stock based on the movements in the options market lately.
|
|
|
GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
|
|
|
GNRC's first-quarter results gain from Residential product sales. Management revised outlook for 2025 owing to higher tariffs and a soft macro backdrop.
|
|
|
MGNI appears to be a better investment option compared to TTD at the moment.
|
|
|
OKE's first-quarter earnings lag estimates, and revenues beat the same. The company's operating income increases during the same period.
|
|
|
Asbury reports lower-than-expected first-quarter results, wherein earnings and revenues decline year over year.
|
|
|
UNM's Q1 results reflect solid performances across most of the segments, partially offset by weakness in the Unum U.S and Corporate segments.
|
|
|
JAKK's Q1 margins benefit from higher margins on new product launches, along with a reduction in inventory obsolescence expenses and retailer markdowns.
|
|
|
Investors need to pay close attention to Alkermes stock based on the movements in the options market lately.
|
|
Search Other Sites